Privia Health
PRVA
249 hedge funds and large institutions have $2.71B invested in Privia Health in 2025 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 87 increasing their positions, 89 reducing their positions, and 17 closing their positions.
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
15% more capital invested
Capital invested by funds: $2.35B → $2.71B (+$361M)
8% more funds holding
Funds holding: 231 → 249 (+18)
0.06% more ownership
Funds ownership: 100.07% → 100.13% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 89
4% less call options, than puts
Call options by funds: $6.61M | Put options by funds: $6.89M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VBA
Van Berkom & Associates
Montreal,
Quebec, Canada
|
+$46.8M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$39.4M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$35.8M |
| 4 |
SAM
Silvercrest Asset Management
New York
|
+$13.3M |
| 5 |
ClearBridge Investments
New York
|
+$9.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$82.6M |
| 2 |
SFM
Soros Fund Management
New York
|
-$13.7M |
| 3 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$7.13M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$6.95M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$6.76M |
PRVA Hedge Fund Activity: Q1 2025 in Review
249 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q1 2025, worth a combined $2.71B — up 15% from $2.35B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new PRVA positions and 17 closed out — a net gain of 19 holders — while 87 added to existing stakes and 89 trimmed.
The largest buyer was Van Berkom & Associates, opening a new position worth an estimated $46.8M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $82.6M.
- 249 institutional investors held Privia Health (PRVA) as of Q1 2025, up from 231 in Q4 2024.
- Funds reported $2.71B of Privia Health stock for Q1 2025, up 15% quarter-over-quarter.
- 36 funds opened new Privia Health positions in Q1 2025 and 17 closed out, a net change of +19 holders.
- The largest Privia Health buyer in Q1 2025 was Van Berkom & Associates, an estimated $46.8M added.
- The largest Privia Health seller in Q1 2025 was T. Rowe Price Investment Management, an estimated $82.6M sold.
Based on aggregated 13F filings for Q1 2025.